Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/7/2024 | $30.50 → $24.00 | Buy → Neutral | BofA Securities |
| 8/20/2024 | $33.00 | Outperform | RBC Capital Mkts |
| 8/19/2024 | Buy | BofA Securities | |
| 8/19/2024 | $29.00 | Buy | Deutsche Bank |
| 8/19/2024 | $29.00 | Overweight | JP Morgan |
| 8/19/2024 | $32.00 | Buy | Goldman |
| 8/19/2024 | $28.00 | Outperform | Mizuho |
| 8/19/2024 | $27.00 | Overweight | Wells Fargo |
SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)
MECHANICSBURG, Pa., Nov. 6, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that its Board of Directors has approved a special stock distribution (the "Distribution") to Select Medical's stockholders of the 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. The Distribution by Select Medical of the special stock distribution will be made on November 25, 2024 (the "Distribution Date") to all
Concentra Group Holdings Parent, Inc. ("Concentra," "we," "us," or "our") (NYSE:CON) today announced results for its third quarter ended September 30, 2024, and the declaration of a cash dividend. "We had a successful quarter and made significant progress on key strategic initiatives and our separation from Select Medical. I am proud of our results, solid execution, and our colleagues' continued dedication to delivering quality patient-centric care," said Keith Newton, Chief Executive Officer of Concentra. Matt DiCanio, President & Chief Financial Officer, added "We expanded our footprint in new and existing areas and achieved some of our highest patient satisfaction scores. With our robu
Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Orlando, Florida. The medical center, Concentra Orlando West, is conveniently located at 6708 Grand National Drive, Orlando, Florida 32819. "We're excited to grow our footprint in Orlando," said Janet Cobb, MD, senior vice president of Concentra medical operations. "We have strong relationships with the employers in the area and look forward to offering them another access point for care." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services from its new location i
3 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)
10-Q - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)
8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)
8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)
Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2024, on Thursday, October 31, 2024, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 1, 2024, at 10:30 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: To
Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes. Concentra will host a conference call regarding its second quarter results on Friday, August 2, 2024, at 10:30am Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll F
BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously
RBC Capital Mkts initiated coverage of Concentra Group Holdings Parent with a rating of Outperform and set a new price target of $33.00
BofA Securities initiated coverage of Concentra Group Holdings Parent with a rating of Buy